The SRV8 was hastily built from the bones of the final pre-production M12. Engine displacement is still 5.7 liters, but here ...
Learn how advances in stabilization, automation, and SR-DLS are making PEI-based transient transfection more efficient, ...
Rocket Pharmaceuticals advances gene therapies for rare diseases. Momentum aligns with broader biotech trends in the Nasdaq ...
A new research paper was published in Volume 16 of Genes & Cancer on October 31, 2025, titled “P3a site-specific and cassette ...
This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...
Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock ...
With agentic AI, the database must evolve from a passive ledger to an active reasoning engine that informs, guides, and ...
Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific ...
Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory ...
Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...
Why Tech Unicorns Choose Adobe Creative Cloud Tech unicorns worldwide are choosing adobe creative cloud key as their go-to creative software suite. This shift to Adobe’s ecosystem isn’t random — it’s ...
Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback